
My Top 3 ASCO Abstracts by Prunella Blinman
I love a good plenary session at ASCO, and this year’s plenary session was one…
I love a good plenary session at ASCO, and this year’s plenary session was one…
Early findings from a new study appear to challenge the current standard practice for immune…
A new retrospective analysis suggests that immunotherapy may be less effective in patients who receive…
Argos Therapeutics Inc., an immuno-oncology company focused on the development and commercialisation of individualised immunotherapies…